Lost password ?
SIPHAT
Stronger pharmacy segment momentum in Q4, alongside a continued surge in debt.
- "Siphat delivered better-than-expected revenue in 2025, reaching TND8.15m versus our estimate of TND7.18m, driven by a strong 77.6% surge in Q4. Pharmacy (retail) sales jumped to TND1.8m in Q4, ..."
Executive summary
Conflicts of Interest
Pages 36
Language English
Publish on January 26, 2026
€ 500
VAT Exl.
You may also be interested by these reports :
FIND A REPORT
SIMPLE, TO THE POINT IDEA GENERATION
Each company is researched in depth using a structured, robust and transparent process. Valuations are disciplined and dispassionate.
AlphaMena allows you to compare stocks along a wide range of parameters be it by sector, by geography or an array of investment themes.
Our reports include actuarial as well as off balance-sheet data and governance metrics.
Priority is given to idea generation through quick, to the point, answers by means of browsing from one idea to the next.